In Rajasthan, 4 new cases of coronavirus infection were reported on Saturday, bringing the total number of cases in the state to 3,09,399. At the same time, five more people died of the infection, bringing the total number of deaths in the state to 2,2705. Officials said five more people had died in the state in the last 24 hours due to the corona virus infection as of 6pm on Saturday.
So far 503 people have died in Jaipur, 291 in Jodhpur, 219 in Ajmer, 116 in Bikaner, 116 in Kota, 110 in Bharatpur, 111 in Udaipur, 109 in Pali and 99 in Sikar. He said 899 people had recovered from the corona virus infection in the state on Saturday. A total of 2,97,819 people have been cured in the state so far. Kovid-19 is currently treating 8,795 people in the state.
Recommendation for ‘covaxine’ approval for emergency use
Meanwhile, an expert committee of the Central Medicine Authority of India on Saturday recommended the approval of the home-developed Covid-19 vaccine ‘Kovacin’ for emergency use with certain conditions. On Friday, the Central Drugs Standards Control Organization’s (CDSCO) Cowid-19 subject matter expert committee (SEC) recommended approval for emergency use of the coronavirus vaccine in Oxford for emergency use in India. In collaboration with the Indian Council of Medical Research (ICMR), India Biotech has developed covaxin domestically.
The vaccine from a Hyderabad-based pharmaceutical firm was reconsidered on Saturday after a submission was handed over to the CDSC’s Committee of Experts (SEC) on Covid-19 for emergency use, sources said. In December, India Biotech filed an application with the Comptroller General of India Pharmaceuticals (DCGI) for approval of the domestically developed covacin vaccine. The SEC on Friday recommended the approval of the Oxford-Astrageneca anti-coronavirus vaccine ‘Covishield’ for emergency use in India.